Imaging outcomes and their role in determining outcomes in osteoarthritis and rheumatoid arthritis

Current Opinion in Rheumatology

Volumn 18, Issue 2, 2006, Pages 157-162

  Hunter, David J ^a,c   Conaghan, Philip G ^b  

^a BOSTON MEDICAL CENTER   (United States)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Musculoskeletal imaging; Osteoarthritis; Rheumatoid arthritis

Indexed keywords

DIAGNOSTIC IMAGING; DISEASE COURSE; ECHOGRAPHY; HUMAN; JOINT RADIOGRAPHY; KNEE MENISCUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOGRAPHY; ULTRASONOGRAPHY;

EID: 33646711641     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bor.0000209427.61904.66     Document Type: Review

References (55)

1. Kellgren JH, Lawrence JS. Atlas of standard radiographs. Oxford: Oxford University Press; 1963.
2. Creamer P. Osteoarthritis pain and its treatment [review]. Curr Opin Rheumatol 2000; 12:450-455.
3. Mazzuca SA, Brandt KD, Lane KA, Katz BP. Knee pain reduces joint space width in conventional standing anteroposterior radiographs of osteoarthritic knees. Arthritis Rheum 2002; 46:1223-1227.
4. Mazzuca SA, Brandt KD. Is knee radiography useful for studying the efficacy of a disease-modifying osteoarthritis drug in humans? [review] Rheum Dis Clin North Am 2003; 29:819-830.
5. Conrozier T, Mathieu P, Piperno M, et al. Lyon Schuss radiographic view of the knee: utility of fluoroscopy for the quality of tibial plateau alignment. J Rheumatol 2004; 31:584-590.
6. Buckland-Wright JC, Ward RJ, Peterfy C, et al. Reproducibility of the semiflexed (metatarsophalangeal) radiographic knee position and automated measurements of medial tibiofemoral joint space width in a multicenter clinical trial of knee osteoarthritis. J Rheumatol 2004; 31:1588-1597.
7. Mazzuca SA, Brandt KD, Buckwalter KA, Lequesne M. Pitfalls in the accurate measurement of joint space narrowing in semiflexed, anteroposterior radiographic imaging of the knee. Arthritis Rheum 2004; 50:2508-2515.
8. Brandt KD, Mazzuca SA, Katz BP, et al. Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial [see comment]. Arthritis Rheum 2005; 52:2015-2025.
9. Altman RD, Bloch DA, Dougados M, et al. Measurement of structural progression in osteoarthritis of the hip: the Barcelona consensus group [review]. Osteoarthr Cartil 2004; 12:515-524.
10. Jacobsen S, Sonne-Holm S, Soballe K, et al. The relationship of hip joint space to self reported hip pain: a survey of 4151 subjects of the Copenhagen City Heart Study: the Osteoarthritis Substudy. Osteoarthr Cartil 2004; 12:692-697.
11. Reijman M, Hazes JM, Pols HA, et al. Role of radiography in predicting progression of osteoarthritis of the hip: prospective cohort study. BMJ 2005; 330:1183.
12. Eckstein F, Glaser C. Measuring cartilage morphology with quantitative magnetic resonance imaging [review]. Semin Musculoskel Radiol 2004; 8:329-353.
13. Wluka AE, Wolfe R, Stuckey S, Cicuttini FM. How does tibial cartilage volume relate to symptoms in subjects with knee osteoarthritis? Ann Rheum Dis 2004; 63:264-268.
14. Cicuttini FM, Jones G, Forbes A, Wluka AE. Rate of cartilage loss at two years predicts subsequent total knee arthroplasty: a prospective study. Ann Rheum Dis 2004; 63:1124-1127.
15. Patel V, Issever AS, Burghardt A, et al. MicroCT evaluation of normal and osteoarthritic bone structure in human knee specimens. J Orthop Res 2003; 21:6-13.
16. Burr DB. The importance of subchondral bone in the progression of osteoarthritis [review]. J Rheumatol Suppl 2004; 70:77-80. An insightful review of the contribution of bone to the etiopathogenesis of osteoarthritis.
17. Burr DB. The importance of subchondral bone in osteoarthrosis [review]. Curr Opin Rheumatol 1998; 10:256-262.
18. Carbone LD, Nevitt MC, Wildy K, et al. The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis. Arthritis Rheum 2004; 50:3516-3525. Although these data are from an observational study, with obvious implications for bias and residual confounding, they provide a fascinating insight into the potential use of antiresorptive therapy in osteoarthritis.
19. Meizer R, Radda C, Stolz G, et al. MRI-controlled analysis of 104 patients with painful bone marrow edema in different joint localizations treated with the prostacyclin analogue iloprost. Wien Klin Wochenschr 2005; 117:278-286.
20. Seedhom BB, Dowson D, Wright V. Proceedings. Functions of the menisci: a preliminary study. Ann Rheum Dis 1974; 33:111.
21. Bhattacharyya T, Gale D, Dewire P, et al. The clinical importance of meniscal tears demonstrated by magnetic resonance imaging in osteoarthritis of the knee [comment]. J Bone Joint Surg Am 2003; 85:4-9.
22. Englund M, Lohmander LS. Risk factors for symptomatic knee osteoarthritis fifteen to twenty-two years after meniscectomy. Arthritis Rheum 2004; 50:2811-2819.
23. Berthiaume MJ, Raynauld JP, Martel-Pelletier J, et al. Meniscal tear and extrusion are strongly associated with progression of symptomatic knee osteoarthritis as assessed by quantitative magnetic resonance imaging. Ann Rheum Dis 2005; 64:556-563.
24. Bukhari M, Harrison B, Lunt M, et al. Time to first occurrence of erosions in inflammatory polyarthritis. Arthritis Rheum 2001; 44:1248-1253.
25. Edmonds J, Saudan A, Lassere M, Scott D. Introduction to reading radiographs by the Scott Modification of the Larsen Method. J Rheumatol 1999; 26:740-742.
26. Van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 1999; 26:743-745.
27. Van der Heijde D, Lee S, Smolen J, et al. How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion. Arthritis Rheum 2002; 47:215-218.
28. Strand V, Sharp JT. Radiographic data from recent randomized controlled trials in rheumatoid arthritis: what have we learned? Arthritis Rheum 2003; 48:21-34.
29. Guillemin F, Billot L, Boini S, et al. Reproducibility and sensitivity to change of 5 methods for scoring hand radiographic damage in patients with rheumatoid arthritis. J Rheumatol 2005; 32:778-786.
30. Bruynesteyn K, van der Heijde D, Boers M, et al. Minimal clinically important difference in radiographic progression over 1 year in rheumatoid arthritis: results of a validation study with clinical experts. J Rheumatol 2001; 28:904-910.
31. Hulsmans HM, Jacobs JW, van der Heijde DM, et al. The course of radiologic damage during the first six years of rheumatoid. Arthritis Rheum 2000; 43:1927-1940.
32. Scott DL, Pugner K, Kaarela K, et al. The links between joint damage and disability in rheumatoid arthritis. Rheumatology (Oxford) 2000; 39:122-132.
33. Khanna D, Ranganath VK, FitzGerald J, et al. Increased radiographic damage scores at the onset of seropositive rheumatoid arthritis in older patients are associated with osteoarthritis of the hands, but not with more rapid progression of damage. Arthritis Rheum 2005; 52:2284-2292.
34. Welsing PM, Landewe RB, van Riel PL, et al. The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis. Arthritis Rheum 2004; 50:2082-2093.
35. Breedveld FC, Han C, Bala M, et al. Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis. Ann Rheum Dis 2005; 64:52-55.
36. Drossaers-Bakker KW, Kroon HM, Zwinderman AH, et al. Radiographic damage of large joints in long-term rheumatoid arthritis and its relation to function. Rheumatology (Oxford) 2000; 39:998-1003.
37. Goupille P, Roulot B, Akoka S, et al. Magnetic resonance imaging: a valuable method for the detection of synovial inflammation in rheumatoid arthritis. J Rheumatol 2001; 28:35-40.
38. McQueen FM, Stewart N, Crabbe J, et al. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset. Ann Rheum Dis 1998; 57:350-356.
39. McGonagle D, Conaghan PG, O'Connor P, et al. The relationship between synovitis and bone changes in early untreated rheumatoid arthritis. Arthritis Rheum 1999; 42:1706-1711.
40. Ostergaard M, Peterfy C, Conaghan P, et al. OMERACT rheumatoid arthritis magnetic resonance imaging studies: core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol 2003; 30:1385-1386.
41. Ostergaard M, Edmonds J, McQueen F, et al. An introduction to the EULAR-OMERACT Rheumatoid Arthritis MRI Reference Image Atlas. Ann Rheum Dis 2005; 64 (Suppl I):i3-i7.
42. Conaghan P, McQueen F, Peterfy C, et al. The evidence for MRI as an outcome measure in proof-of-concept rheumatoid arthritis studies. J Rheumatol 2005; 32:2465-2469.
43. Quinn MA, Conaghan PG, O'Connor PJ, et al. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal. Arthritis Rheum 2005; 52:27-35.
44. Ostergaard M, Duer A, Nielsen H, et al. Magnetic resonance imaging for accelerated assessment of drug effect and prediction of subsequent radiographic progression in rheumatoid arthritis: a study of patients receiving combined anakinra and methotrexate treatment. Ann Rheum Dis 2005; 64:1503-1506.
45. Perry D, Stewart N, Benton N, et al. Detection of erosions in the rheumatoid hand: a comparative study of multidetector computerized tomography versus magnetic resonance scanning. J Rheumatol 2005; 32:256-267.
46. Conaghan PG, O'Connor P, McGonagle D, et al. Elucidation of the relationship between synovitis and bone damage: a randomised magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis. Arthritis Rheum 2003; 48:64-71.
47. Ostergaard M, Hansen M, Stoltenberg M, et al. Magnetic resonance imaging-determined synovial membrane volume as a marker of disease activity and a predictor of progressive joint destruction in the wrists of patients with rheumatoid arthritis. Arthritis Rheum 1999; 42:918-929.
48. McQueen FM, Benton N, Perry D, et al. Bone oedema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage at the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum 2003; 48:1814-1827.
49. Benton N, Stewart N, Crabbe J, et al. MRI of the wrist in early rheumatoid arthritis can be used to predict functional outcome at 6 years. Ann Rheum Dis 2004; 63:555-561.
50. McQueen F, Beckley V, Crabbe J, et al. Magnetic resonance imaging evidence of tendinopathy in early rheumatoid arthritis predicts tendon rupture at six years. Arthritis Rheum 2005; 52:744-751.
51. Ejbjerg BJ, Vestergaard A, Jacobsen S, et al. The smallest detectable difference and sensitivity to change of magnetic resonance imaging and radiographic scoring of structural joint damage in rheumatoid arthritis finger, wrist, and toe joints: a comparison of the OMERACT rheumatoid arthritis magnetic resonance imaging score applied to different joint combinations and the Sharp/van der Heijde radiographic score. Arthritis Rheum 2005; 52:2300-2306.
52. Wakefield RJ, Balint P, Szkudlarek M, et al. Proceedings from the OMERACT Special Interest Group for Musculoskeletal Ultrasound including definitions for ultrasonographic pathology. J Rheumatol 2005; 32:2485-2487.
53. Wakefield RJ, Brown AK, O'Connor PJ, Emery P. Power Doppler sonography: improving disease activity assessment in inflammatory musculoskeletal disease. Arthritis Rheum 2003; 48:285-288.
54. Ostergaard M, Wiell C. Ultrasonography in rheumatoid arthritis: a very promising method still needing more validation. Curr Opin Rheumatol 2004; 16:223-230.
55. Taylor PC, Steuer A, Gruber J, et al. Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis. Arthritis Rheum 2004; 50:1107-1116.